Detection of Streptococcus pyogenes M1UK in Australia and characterization of the mutation driving enhanced expression of superantigen SpeA
-
Published:2023-02-24
Issue:1
Volume:14
Page:
-
ISSN:2041-1723
-
Container-title:Nature Communications
-
language:en
-
Short-container-title:Nat Commun
Author:
Davies Mark R.ORCID, Keller Nadia, Brouwer StephanORCID, Jespersen Magnus G.ORCID, Cork Amanda J.ORCID, Hayes Andrew J.ORCID, Pitt Miranda E.ORCID, De Oliveira David M. P.ORCID, Harbison-Price NichaelaORCID, Bertolla Olivia M., Mediati Daniel G., Curren Bodie F.ORCID, Taiaroa George, Lacey Jake A.ORCID, Smith Helen V.ORCID, Fang Ning-Xia, Coin Lachlan J. M., Stevens Kerrie, Tong Steven Y. C.ORCID, Sanderson-Smith MartinaORCID, Tree Jai J., Irwin Adam D.ORCID, Grimwood Keith, Howden Benjamin P.ORCID, Jennison Amy V., Walker Mark J.ORCID
Abstract
AbstractA new variant of Streptococcus pyogenes serotype M1 (designated ‘M1UK’) has been reported in the United Kingdom, linked with seasonal scarlet fever surges, marked increase in invasive infections, and exhibiting enhanced expression of the superantigen SpeA. The progenitor S. pyogenes ‘M1global’ and M1UK clones can be differentiated by 27 SNPs and 4 indels, yet the mechanism for speA upregulation is unknown. Here we investigate the previously unappreciated expansion of M1UK in Australia, now isolated from the majority of serious infections caused by serotype M1 S. pyogenes. M1UK sub-lineages circulating in Australia also contain a novel toxin repertoire associated with epidemic scarlet fever causing S. pyogenes in Asia. A single SNP in the 5’ transcriptional leader sequence of the transfer-messenger RNA gene ssrA drives enhanced SpeA superantigen expression as a result of ssrA terminator read-through in the M1UK lineage. This represents a previously unappreciated mechanism of toxin expression and urges enhanced international surveillance.
Funder
Department of Health | National Health and Medical Research Council
Publisher
Springer Science and Business Media LLC
Subject
General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry,Multidisciplinary
Reference77 articles.
1. Walker, M. J. et al. Disease manifestations and pathogenic mechanisms of Group A Streptococcus. Clin. Microbiol. Rev. 27, 264–301 (2014). 2. Carapetis, J. R., Steer, A. C., Mulholland, E. K. & Weber, M. The global burden of group A streptococcal diseases. Lancet Infect. Dis. 5, 685–694 (2005). 3. Hand, R. M., Snelling, T. L. & Carapetis, J. R. Hunter’s Tropical Medicine and Emerging Infectious Diseases 10th edn (eds Ryan, E. T., Hill, D. R., Solomon, T., Aronson, N. E. & Endy, T. P.) 429–438 (Elsevier, 2020). 4. Katz, A. R. & Morens, D. M. Severe streptococcal infections in historical perspective. Clin. Infect. Dis. 14, 298–307 (1992). 5. Guy, R. et al. Increase in scarlet fever notifications in the United Kingdom, 2013/2014. Eur. Surveill. 19, 20749 (2014).
Cited by
50 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|